News | Lung Imaging | October 05, 2015

Four-year post-treatment survival jumped 25 percent among patients who relapsed within 24 months

lung cancer survival rates, CT scan follow-up, computed tomography, improvement, ERS International Congress 2015

October 5, 2015 — Patients with recurrent lung cancer have better post-surgery survival rates if their management includes a follow-up program based on computer tomography (CT) of the chest, according to new findings.

The findings, presented at the European Respiratory Society (ERS) International Congress 2015 in Amsterdam, are the first to show improved overall survival after surgery for a CT-based follow-up program and could change the way patients are currently managed.

Previous research has confirmed that after the introduction of the CT-based follow-up, most cases of recurrent lung cancer can be detected before the patient has any symptoms. This allows for earlier diagnosis and leads to an improved chance of having a radical treatment against the relapse. This new study aimed to assess whether this follow-up also improved survival rates.

Researchers from the Odense University Hospital in Denmark assessed 391 patients who had surgery following a lung cancer diagnosis between 2008 and 2013. After the introduction of a CT- based follow-up in July 2010, all patients receives a scan every third month for two years and then every six months for three years. In May 2015, researchers recorded whether the patients were alive and free from lung cancer.

Results showed the number of patients alive four years after surgery increased from 54 percent to an estimated 68 percent. Additionally, for patients experiencing a relapse during the first 24 months after surgery, the chance of being alive four years after the first treatment increased from 2 percent to an estimated 27 percent.

Niels-Christian Hansen, M.D., presenting author on the study, commented: "Our results show a significant improvement for survival rates for patients post-surgery in a CT follow-up program currently running in Denmark. A key strength of our study is the real-life setting we used, where we were able to demonstrate successful results in a representative sample of lung cancer patients from Denmark. This is very encouraging news and we believe that our results could contribute to the planning of similar treatment programs in other centers and countries."

The authors plan to repeat the same kind of analysis for the group of lung cancer patients treated by radiation with the aim to cure, instead of by surgery, to see if the results are also successful for this group of patients.

The Danish Lung Cancer Group has funded a first preliminary report (in Danish) in November 2014. No other external funding has taken place.

For more information: www.erscongress.org


Related Content

News | Pediatric Imaging

May 2, 2024 — Head and abdominal trauma is a leading cause of death for children. About 1%–2% of children who come to ...

Time May 02, 2024
arrow
Feature | Radiology Business

Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
News | Enterprise Imaging

April 25, 2024 — International medical imaging IT and cybersecurity company Sectra has signed two contracts to provide ...

Time April 25, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group, led by authors at the University of Toronto, have developed an approach for ...

Time April 23, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Therapy

March 28, 2024 — RefleXion Medical, Inc., a therapeutic oncology company, and Limbus AI, Inc., a provider of software ...

Time March 28, 2024
arrow
News | Coronavirus (COVID-19)

March 21, 2024 — Artificial intelligence can spot COVID-19 in lung ultrasound images much like facial recognition ...

Time March 21, 2024
arrow
Subscribe Now